- Company Overview for ENVISION PHARMA MIDCO LIMITED (10117923)
- Filing history for ENVISION PHARMA MIDCO LIMITED (10117923)
- People for ENVISION PHARMA MIDCO LIMITED (10117923)
- Charges for ENVISION PHARMA MIDCO LIMITED (10117923)
- Registers for ENVISION PHARMA MIDCO LIMITED (10117923)
- More for ENVISION PHARMA MIDCO LIMITED (10117923)
Date (document was filed at Companies House) | Type | Description (of the document filed at Companies House) | View / Download (PDF file, link opens in new window) |
---|---|---|---|
29 Oct 2024 | AP01 | Appointment of Mr. Adam Brent Deutsch as a director on 20 August 2024 | |
10 Sep 2024 | AA | Audit exemption subsidiary accounts made up to 31 December 2023 | |
10 Sep 2024 | PARENT_ACC | Consolidated accounts of parent company for subsidiary company period ending 31/12/23 | |
10 Sep 2024 | GUARANTEE2 | Audit exemption statement of guarantee by parent company for period ending 31/12/23 | |
10 Sep 2024 | AGREEMENT2 | Notice of agreement to exemption from audit of accounts for period ending 31/12/23 | |
29 Jul 2024 | RESOLUTIONS |
Resolutions
|
|
24 Jul 2024 | SH01 |
Statement of capital following an allotment of shares on 9 July 2024
|
|
17 Apr 2024 | CS01 | Confirmation statement made on 10 April 2024 with no updates | |
12 Apr 2024 | PSC05 | Change of details for Envision Pharma Finco Limited as a person with significant control on 10 November 2020 | |
11 Apr 2024 | PSC05 | Change of details for Envision Pharma Finco as a person with significant control on 10 November 2020 | |
27 Sep 2023 | AP01 | Appointment of Mr Howard Collins Miller Iii as a director on 12 September 2023 | |
26 Sep 2023 | TM01 | Termination of appointment of Margaret Heim as a director on 2 August 2023 | |
26 Sep 2023 | AA | Audit exemption subsidiary accounts made up to 31 December 2022 | |
26 Sep 2023 | PARENT_ACC | Consolidated accounts of parent company for subsidiary company period ending 31/12/22 | |
26 Sep 2023 | AGREEMENT2 | Notice of agreement to exemption from audit of accounts for period ending 31/12/22 | |
26 Sep 2023 | GUARANTEE2 | Audit exemption statement of guarantee by parent company for period ending 31/12/22 | |
21 Apr 2023 | CS01 | Confirmation statement made on 10 April 2023 with updates | |
22 Mar 2023 | AP01 | Appointment of Mrs Margaret Heim as a director on 21 February 2023 | |
22 Feb 2023 | SH01 |
Statement of capital following an allotment of shares on 6 February 2023
|
|
21 Sep 2022 | AA | Audit exemption subsidiary accounts made up to 31 December 2021 | |
21 Sep 2022 | PARENT_ACC | Consolidated accounts of parent company for subsidiary company period ending 31/12/21 | |
21 Sep 2022 | GUARANTEE2 | Audit exemption statement of guarantee by parent company for period ending 31/12/21 | |
21 Sep 2022 | AGREEMENT2 | Notice of agreement to exemption from audit of accounts for period ending 31/12/21 | |
27 Jul 2022 | PSC05 | Change of details for Envision Pharma Finco Limited as a person with significant control on 10 November 2020 | |
27 Jun 2022 | AD03 | Register(s) moved to registered inspection location 12 New Fetter Lane London EC4A 1JP |